Traverse 2024 Study. Learn about findings, participation, and its impact on patient care. The results, from the phase 4 traverse study, showed a negligible difference in cv events among men aged 45 to 80 years with hypogonadism who were treated with.


Traverse 2024 Study

Traverse was the first study to demonstrate that functional symptom improvement is closely related to correction of anaemia. Mohit khera, a significant study in urology research.

Traverse 2024 Study Images References :